Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Supraphysiological glutamine as a means of depleting intracellular amino acids to enhance pancreatic cancer chemosensitivity.
Muranaka H, Billet S, Cruz-Hernández C, Ten Hoeve J, Gonzales G, Elmadbouh O, Zhang L, Smith B, Tighiouart M, You S, Edderkaoui M, Hendifar A, Pandol S, Gong J, Bhowmick N. Muranaka H, et al. Among authors: tighiouart m. Res Sq [Preprint]. 2023 Nov 30:rs.3.rs-3647514. doi: 10.21203/rs.3.rs-3647514/v1. Res Sq. 2023. PMID: 38076821 Free PMC article. Preprint.
Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma.
Kim ES, Kies MS, Fossella FV, Glisson BS, Zaknoen S, Statkevich P, Munden RF, Summey C, Pisters KM, Papadimitrakopoulou V, Tighiouart M, Rogatko A, Khuri FR. Kim ES, et al. Among authors: tighiouart m. Cancer. 2005 Aug 1;104(3):561-9. doi: 10.1002/cncr.21188. Cancer. 2005. PMID: 16028213 Free article. Clinical Trial.
Translation of innovative designs into phase I trials.
Rogatko A, Schoeneck D, Jonas W, Tighiouart M, Khuri FR, Porter A. Rogatko A, et al. Among authors: tighiouart m. J Clin Oncol. 2007 Nov 1;25(31):4982-6. doi: 10.1200/JCO.2007.12.1012. J Clin Oncol. 2007. PMID: 17971597
A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
Sinha R, Kaufman JL, Khoury HJ Jr, King N, Shenoy PJ, Lewis C, Bumpers K, Hutchison-Rzepka A, Tighiouart M, Heffner LT, Lechowicz MJ, Lonial S, Flowers CR. Sinha R, et al. Among authors: tighiouart m. Cancer. 2012 Jul 15;118(14):3538-48. doi: 10.1002/cncr.26660. Epub 2012 Jan 3. Cancer. 2012. PMID: 22535574 Free article. Clinical Trial.
117 results